ProPhase Labs, Inc. (PRPH)
OTCMKTS · Delayed Price · Currency is USD
0.2049
-0.0071 (-3.35%)
At close: Jan 8, 2026
ProPhase Labs Market Cap
ProPhase Labs has a market cap or net worth of $946.21 thousand as of January 8, 2026. Its market cap has decreased by -93.93% in one year.
Market Cap
946.21K
Enterprise Value
8.23M
Revenue
5.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.20
Market Cap Chart
Since January 2, 1996, ProPhase Labs's market cap has decreased from 5.04M to 946.21K, a decrease of -81.23%. That is a compound annual growth rate of -5.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 979.00K | -52.63% |
| Dec 31, 2025 | 2.07M | -88.57% |
| Dec 31, 2024 | 18.08M | -77.84% |
| Dec 29, 2023 | 81.56M | -47.97% |
| Dec 30, 2022 | 156.75M | 41.18% |
| Dec 31, 2021 | 111.03M | 4.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Glass House Brands | 723.98M |
| Elite Pharmaceuticals | 503.78M |
| Northwest Biotherapeutics | 445.03M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 365.15M |
| Silence Therapeutics | 273.96M |